Home › Neuroblastoma › Virginia
Neuroblastoma clinical trials in Virginia
3 studies for Neuroblastoma are looking for participants at sites in Virginia.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Virginia Cancer Center, Charlottesville
- Naval Medical Center - Portsmouth, Portsmouth
RecruitingPhase 3
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Virginia Commonwealth University, Richmond
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Virginia Commonwealth University, Richmond
RecruitingPhase 2
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.